Theseus Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Cash & Equivalents	96.67	409.11	326.88	12.05	329.98	Upgrade
Short-Term Investments	844.81	321.7	250	-	-	Upgrade
Cash & Short-Term Investments	941.48	730.81	576.88	12.05	329.98	Upgrade
Cash Growth	28.83%	26.68%	4688.21%	-96.35%	4012.44%	Upgrade
Accounts Receivable	817.01	865.81	1,237	927.67	743.61	Upgrade
Other Receivables	0.34	2.42	8.84	2.75	-	Upgrade
Receivables	820.76	878.26	1,262	949.22	794.11	Upgrade
Inventory	1,102	1,327	1,251	2,097	1,779	Upgrade
Prepaid Expenses	21.95	75.8	32.68	40.12	23.13	Upgrade
Other Current Assets	122.85	201.29	185.33	313.89	192.07	Upgrade
Total Current Assets	3,009	3,213	3,308	3,412	3,118	Upgrade
Property, Plant & Equipment	1,358	1,366	1,380	1,392	1,328	Upgrade
Long-Term Investments	-	-	3.49	3.44	2.84	Upgrade
Other Intangible Assets	265.23	278.26	284.74	309.31	334.32	Upgrade
Long-Term Deferred Charges	6.9	8.4	-	-	-	Upgrade
Other Long-Term Assets	60.63	39.97	51.61	63.82	105.4	Upgrade
Total Assets	4,699	4,906	5,027	5,181	4,888	Upgrade
Accounts Payable	650.96	1,229	1,250	1,381	1,636	Upgrade
Accrued Expenses	431.86	464.99	579.15	655.29	537	Upgrade
Short-Term Debt	-	-	-	429.06	-	Upgrade
Current Portion of Long-Term Debt	-	-	-	47.97	163.79	Upgrade
Current Portion of Leases	54.44	10.28	11.99	4.54	3.98	Upgrade
Current Income Taxes Payable	20.75	-	12.68	-	15.85	Upgrade
Other Current Liabilities	146.05	167.99	166.3	212.97	152.77	Upgrade
Total Current Liabilities	1,304	1,873	2,020	2,730	2,510	Upgrade
Long-Term Debt	-	-	-	45.62	115.54	Upgrade
Long-Term Leases	67.92	27.07	37.35	6.01	10.55	Upgrade
Long-Term Deferred Tax Liabilities	47.08	57.64	113.06	49.02	12.57	Upgrade
Other Long-Term Liabilities	27.27	26.78	-	-	-	Upgrade
Total Liabilities	1,446	1,984	2,171	2,831	2,648	Upgrade
Common Stock	178.8	178.8	178.8	178.8	178.8	Upgrade
Additional Paid-In Capital	970.15	970.15	970.15	970.15	970.15	Upgrade
Retained Earnings	2,093	1,767	1,693	1,177	1,069	Upgrade
Comprehensive Income & Other	11.26	5.68	14.13	24.42	21.93	Upgrade
Shareholders' Equity	3,253	2,922	2,856	2,350	2,240	Upgrade
Total Liabilities & Equity	4,699	4,906	5,027	5,181	4,888	Upgrade
Total Debt	122.36	37.35	49.34	533.2	293.85	Upgrade
Net Cash (Debt)	819.12	693.46	527.55	-521.15	36.13	Upgrade
Net Cash Growth	18.12%	31.45%	-	-	-	Upgrade
Net Cash Per Share	45.81	38.79	29.51	-29.15	2.02	Upgrade
Filing Date Shares Outstanding	17.88	17.88	17.88	17.88	17.88	Upgrade
Total Common Shares Outstanding	17.88	17.88	17.88	17.88	17.88	Upgrade
Working Capital	1,705	1,341	1,287	681.82	608.54	Upgrade
Book Value Per Share	181.93	163.42	159.76	131.44	125.28	Upgrade
Tangible Book Value	2,988	2,644	2,572	2,041	1,906	Upgrade
Tangible Book Value Per Share	167.09	147.86	143.83	114.14	106.58	Upgrade
Land	407.5	407.5	407.5	402	402	Upgrade
Buildings	350.47	345.16	347.57	327.04	325.1	Upgrade
Machinery	1,080	1,197	1,184	1,147	999.26	Upgrade
Construction In Progress	78.66	55.25	29.09	55.04	20.62	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.